PAIN+ CPN

Print Return

Doctor, if I take duloxetine for chronic musculoskeletal pain, could adding an online pain coping program help me more?

Adding a self-guided online cognitive behavioural therapy (CBT) program called PainTRAINER to duloxetine did not improve pain more than duloxetine alone after 24 weeks. Adding brief phone-based motivational interviewing also did not improve pain or increase completion of the online program.

What is the evidence?

SUMMARY OF FINDINGS

Duloxetine plus web-based CBT compared with duloxetine alone.

Outcome at 24 weeks

Duloxetine alone

Duloxetine + web-based CBT*

Effect

Overall pain severity**3.613.62No important difference between groups

Pain intensity**

3.79

3.78

No important difference between groups

Pain interference**3.523.54No important difference between groups

*Results shown for the two groups receiving PainTRAINER combined: with and without phone-based motivational interviewing.

**Measured using the Brief Pain Inventory (BPI), where higher scores mean worse pain or greater interference. A change of about 1 point is considered clinically important.

The differences between groups were very small and were not statistically significant.

Phone-based motivational interviewing also did not increase use of PainTRAINER. About 46% of people completed six or more of the eight online modules, whether or not they received phone support.

What kind of study was this?

This was a randomized controlled trial(RCT). In an RCT, patients are assigned by chance to go in one treatment group or the other treatment group so researchers can compare their outcomes.

Who? This study included 281 adults with chronic musculoskeletal pain recruited from primary care clinics in North Carolina. Participants had experienced daily pain for at least three months affecting the low back, neck, hip, knee, or multiple areas of the body, and had at least moderate pain. Their average age was 55 years and about two-thirds were women.

Before being randomized, everyone took 30 mg of duloxetine for one week. Only people who could tolerate duloxetine and were willing to increase to 60 mg per day continued into the trial. Sixty-six potential participants (18.5%) did not continue because of side effects, most commonly nausea.

What? The study compared three treatments over 24 weeks:

Treatment

vs

Another treatment

Duloxetine + PainTRAINER without phone support: Participants took duloxetine 60 mg once daily and were offered PainTRAINER, a self-guided online cognitive behavioural therapy (CBT) program.

PainTRAINER included eight 35- to 45-minute modules teaching relaxation, problem solving, balancing activity and rest, pleasant activity scheduling, and reframing negative thoughts.

Duloxetine + PainTRAINER with phone support: One of the two PainTRAINER groups also received six approximately 15-minute phone calls using motivational interviewing. These calls were intended to encourage participants to complete the modules and practise the coping skills they learned.


Participants took duloxetine 60 mg once daily.

Why was this research done?

Chronic musculoskeletal pain can affect physical, emotional, and social well-being. Cognitive behavioural therapy (CBT) can help some people manage chronic pain, but access to in-person CBT may be limited by factors such as cost, travel, scheduling, and the availability of trained therapists. Self-guided online CBT programs may provide another way for people to learn pain coping skills. The researchers wanted to know whether adding the PainTRAINER online CBT program to duloxetine would improve pain more than duloxetine alone. They also wanted to know whether brief motivational interviewing by phone would encourage people to use the program more and improve their outcomes.

After 24 weeks, adding PainTRAINER did not provide additional improvement in overall pain, pain intensity, or pain interference compared with duloxetine alone. Phone support also did not increase completion of PainTRAINER or improve pain outcomes. This means the study does not show that CBT in general is ineffective for chronic pain; it tells us that offering this particular self-guided program alongside duloxetine did not provide additional pain relief in this study.

There are some important limitations. Everyone in the study received duloxetine, so this study cannot tell us how well duloxetine works compared with no duloxetine or placebo. It also only included people who were able to tolerate duloxetine during the initial one-week period. Finally, just under half of participants using PainTRAINER completed at least six of its eight modules, so it remains uncertain whether the results would have been different if more participants had completed the program.

Although this study did not find that adding PainTRAINER improved pain overall, an earlier study of a related online program called PainCOACH, in which 91% of participants completed all eight modules, found improvements in some pain-related outcomes. In the current study, participants who completed more modules also reported less pain, although this does not prove that greater use of the program caused better outcomes. Taken together, these findings leave some uncertainty about the effectiveness of online pain coping programs when participants engage more fully with them.

This Evidence Summary is based on the following article:

Ang D, Kaplan S, Keefe F, et al. Duloxetine and cognitive behavioral therapy with phone-based support for the treatment of chronic musculoskeletal pain: a randomized controlled trial. Pain. 2026 Mar 1;167(3):577-588. doi: 10.1097/j.pain.0000000000003861. Epub 2025 Dec 23. PubMed

Published: Monday, September 28, 2026

Please note that the information contained herein is not to be interpreted as an alternative to medical advice from a professional healthcare provider. If you have any questions about any medical matter, you should consult your professional healthcare providers, and should never delay seeking medical advice, disregard medical advice or discontinue medication based on information provided here.

This Evidence Summary was printed from the PAIN+ CPN website on 2026/10/02.

To view other Evidence Summaries or to register to receive email notifications about new Evidence Summaries, please visit us at https://www.painpluscpn.ca/Articles/EvidenceSummaries
EvidenceSummary QR Code